Diamond Biotechnology Co., Ltd (6815) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Diamond Biotechnology Co., Ltd (6815:TWSE), powered by AI.

Current Price
$31.05
Sector
Healthcare
What is the Diamond Biotechnology Co., Ltd stock price forecast?

Diamond Biotechnology Co., Ltd is currently trading at $31.05. View real-time AI analysis on Alpha Lenz.

What is Diamond Biotechnology Co., Ltd insider trading activity?

View the latest insider trading data for Diamond Biotechnology Co., Ltd on Alpha Lenz.

What is Diamond Biotechnology Co., Ltd's P/E ratio?

View Diamond Biotechnology Co., Ltd's valuation metrics on Alpha Lenz.

Diamond Biotechnology Co., Ltd

TWSE · 6815
NT$31.05+0.05(+0.16%)
Ask about Diamond Biotechnology Co., Ltd's future dividend policy...
Alpha Chat Insight

Diamond Biotechnology Co., Ltd's ROE is -12.1%. Explore profitability and growth together.

Ask for details

Company Overview

Diamond Biotechnology Co., Ltd is a healthcare company specializing in the research, development, manufacture, and sale of medical equipment and skincare products. Founded in 2014 and headquartered in Taipei, the company operates across both domestic and international markets, offering innovative skincare solutions under the Timera and Diamond Beauty brands as well as leasing medical devices. Its product portfolio includes facial masks, lotions, creams, essences, and specialized equipment such as sonic wave and radio wave devices, frozen fat reduction machines, and micro-plastic surgery consumables like botulinum and collagen injections—all aimed at improving skin health and aesthetic outcomes. In addition to product sales, Diamond Biotechnology provides consulting services in medical beauty management and leases specialized equipment to clinics and industry professionals. Positioned within the healthcare sector and medical equipment industry, the company plays a crucial role in enhancing personal care standards and supporting medical practitioners with advanced technology solutions. With sustained revenue growth and a diversified product lineup, Diamond Biotechnology Co., Ltd contributes significantly to the development and modernization of medical aesthetics and skin care in Taiwan and abroad.

SectorHealthcare
IndustryMedical Devices
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$501.49MRevenue
0.00Shares Out
0Employees

Margins

30.96%Gross
-6.82%EBITDA
-14.79%Operating
-15.92%Pre-Tax
-14.02%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

4.87%Rev 3Yr
10.36%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-7.30%ROA
-12.07%ROE
-7.76%ROIC

Financial Health

NT$146.09MCash & Cash Equivalents
NT$181.03MNet Debt
60.37%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Diamond Biotechnology Co., Ltd (ticker: 6815) is a company listed on TWSE in the Healthcare sector (Medical Devices).

The current price is 31.05 with a P/E ratio of -x and P/B of -x.

ROE is -12.07% and operating margin is -14.79%. Annual revenue is $501M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Diamond Biotechnology Co., Ltd (6815) Stock Forecast 2026 $31.05 — Price, Financials & Analyst Targets | Alpha Lenz